NanoViricides Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for NanoViricides stock have an average target of $6.00, which predicts a 368.75% increase from the current stock price of 1.28.

Price Target: $6.00 (+368.75%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$6.00	$6.00	$6.00	$6.00
Change	+368.75%	+368.75%	+368.75%	+368.75%

Analyst Ratings

The average analyst rating for NanoViricides stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Dec '25	Apr '26	May '26	Jul '26	Aug '26
Strong Buy	1	1	1	2	2
Buy	0	0	0	0	0
Hold	0	0	0	0	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	1	1	1	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Robert LeBoyer Noble Financial	Noble Financial	Buy Reiterates $6	Buy	Reiterates	$6	+368.75%	Sep 24, 2026
James Molloy Alliance Global Partners	Alliance Global Partners	Buy Reiterates $6	Buy	Reiterates	$6	+368.75%	May 26, 2026

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

76.50M

EPS This Year

-0.35

from -0.41

EPS Next Year

-0.35

from -0.35

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026	Jun 30, 2027
Revenue	-	-	-	-	-	-
Operating Income	-8.11M	-8.94M	-8.52M	-9.59M	-8.31M	-12.51M
Net Income	-8.11M	-8.59M	-8.29M	-9.47M	-8.22M	-12.46M
EPS	-	-	-	-	-0.41	-0.35
Free Cash Flow	-	-	-	-	-	-3.80M
No. Analysts	-	-	-	-	-	1

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2027	2028	2029
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Chart

Revenue Growth	2028	2029
High	-
Avg	-
Low	-

EPS Forecast

Chart

EPS	2027	2028	2029
High	-0.35
Avg	-0.35
Low	-0.35

EPS Growth

Chart

EPS Growth	2027	2028	2029
High	-
Avg	-
Low	-